TAS102 in Patients With ER-positive, HER2-negative Advanced Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Neoplasm|Chemotherapy Effect
Interventions: DRUG: trifluridine/tipiracil
Sponsor: Borstkanker Onderzoek Groep
Collaborators: Erasmus Medical Center|UMC Utrecht|Servier|BOOG Study Center